艾司西酞普兰对伴健康焦虑的功能性胃肠道疾病的临床疗效  

Clinical efficacy of escitalopram in treating functional gastrointestinal disorder patients with health anxiety

作　　者：邱冬妮[1] 徐三荣[1] 蒋蔚茹[1] 陈坚[1] 黄剑平[1] 蒋晓芸[1] 邱志兵[1] 岳文杰[1] 罗忠光 刘杰[1] 

机构地区：[1]复旦大学附属华山医院消化科,上海200040

出　　处：《国际消化病杂志》2015年第5期359-362,共4页International Journal of Digestive Diseases

摘　　要：目的评价艾司西酞普兰联合胃肠动力药物对伴有健康焦虑的功能性胃肠道疾病(FGID)患者的临床疗效。方法入选伴有健康焦虑的FGID患者42例,根据原先的精神用药分为黛力新组和其他精神药物组(以下简称其他组),用艾司西酞普兰取代黛力新或原来的精神治疗药物,并继续联合使用原来的胃肠动力药物进行治疗,评价患者胃肠道症状的改善情况。结果黛力新组有效率为90.5%,临床痊愈率为81.0%;其他组有效率为80.0%,临床痊愈率为60%;总有效率为85.4%,临床痊愈率为70.7%。结论艾司西酞普兰联合胃肠动力药物对伴有健康焦虑的FGID患者有较好的疗效。Objective This paper investigated the clinical efficacy of escitalopram in treating functional gastrointestinal disorder patients with health anxiety .Methods 42 patients were divided into two groups ,the deanxit group and the other psychiatric drugs group （here after referred to as＂the other group＂） ,according to their primary psychiatric medication .Their primary psychiatric medication was replaced with escitalopram and continued treating with primary gastrointestinal drugs as a combination therapy .Results A 90 .5% of efficacy and an 81 .0% of remission were obtained in the deanxit group ,while only an 80 .0% of efficacy and a 60% of remission were obtained in the other group .A total 85 .4% efficacy and 70 .7% of remission were obtained in all patients .Conclusion Escitalopram and gastrointestinal drugs used as a combination had high clinical efficacy in treating functional gastrointestinal disorder patients with health anxiety .

关 键 词：艾司西酞普兰 功能性胃肠道疾病 健康焦虑 疗效 

分 类 号：R57[医药卫生—消化系统] R749[医药卫生—内科学]